People / Staff

Francesc Villarroya Gombau

Search publications

Publications

  • Planavila A, Redondo-Angulo I, Ribas F, Garrabou G, Casademont J, Giralt M and Villarroya-Gombau F.

    Fibroblast growth factor 21 protects the heart from oxidative stress.

    CARDIOVASC RES . 106(1): 19-31. Number of citations: 209

    [doi:10.1093/cvr/cvu263]

  • Cereijo R, Giralt M and Villarroya-Gombau F.

    Thermogenic brown and beige/brite adipogenesis in humans.

    ANNALS OF MEDICINE . 47(2): 169-177. Number of citations: 68

    [doi:10.3109/07853890.2014.952328]

  • Sheedfar F, Vermeer M, Pazienza V, Villarroya-Terrade J, Rappa F, Cappello F, Mazzoccoli G, Villarroya-Gombau F, van der Molen H, Hofker MH, Koonen DP and Vinciguerra M.

    Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.

    INTERNATIONAL JOURNAL OF OBESITY . 39(2): 331-338. Number of citations: 19

    [doi:10.1038/ijo.2014.91]

  • Domingo P, Lamarca MK, Gallego-Escuredo JM, Torres F, Domingo JC, Villarroya-Terrade J, Gutierrez Mdel M, Mateo MG, Vidal F, Villarroya-Gombau F and Giralt M.

    Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 70(6): 1825-1832. Number of citations: 11

    [doi:10.1093/jac/dkv027]

  • Guzmán-Ruiz R, Ortega F, Rodríguez A, Vázquez-Martínez R, Díaz-Ruiz A, Garcia-Navarro S, Giralt M, Garcia-Rios A, Cobo-Padilla D, Tinahones FJ, López-Miranda J, Villarroya-Gombau F, Frühbeck G, Fernández-Real JM and Malagón MM.

    Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in ß-cells.

    INTERNATIONAL JOURNAL OF OBESITY . 38(12): 1545-1554. Number of citations: 76

    [doi:10.1038/ijo.2014.36]

  • Villarroya-Terrade J, Flachs P, Redondo-Angulo I, Giralt M, Medrikova D, Villarroya-Gombau F, Kopecky J and Planavila A.

    Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.

    Lipids . 49(11): 1081-1089. Number of citations: 20

    [doi:10.1007/s11745-014-3948-x]

  • Beiroa D, Imbernon M, Gallego R, Senra A, Herranz D, Villarroya-Gombau F, Serrano M, Fernø J, Salvador J, Escalada J, Dieguez C, Lopez M, Frühbeck G and Nogueiras R.

    GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.

    Diabetes . 63(10): 3346-3358. Number of citations: 427

    [doi:10.2337/db14-0302]

  • Domingo P, Gutierrez Mdel M, Gallego-Escuredo JM, Torres F, Mateo MG, Villarroya-Terrade J, Lamarca K, Domingo JC, Vidal F, Villarroya-Gombau F and Giralt M.

    A 48-week study of fat molecular alterations in HIV naive patients starting tenofovir/emtricitabine with lopinavir/ritonavir or efavirenz.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 66(5): 457-465. Number of citations: 13

    [doi:10.1097/QAI.0000000000000205]

  • Hondares E, Gallego-Escuredo JM, Flachs P, Frontini A, Cereijo R, Goday A, Perugini J, Kopecky P, Giralt M, Cinti S, Kopecky J and Villarroya-Gombau F.

    Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 63(3): 312-317. Number of citations: 72

    [doi:10.1016/j.metabol.2013.11.014]

  • Gallego-Escuredo JM, Villarroya-Terrade J, Domingo P, Targarona EM, Alegre M, Domingo JC, Villarroya-Gombau F and Giralt M.

    Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 64(2): 142-148. Number of citations: 27

    [doi:10.1097/QAI.0b013e31829bdb67]